PRIMOPUS Trademark

Trademark Overview


On Friday, December 9, 2022, a trademark application was filed for PRIMOPUS with the United States Patent and Trademark Office. The USPTO has given the PRIMOPUS trademark a serial number of 79373510. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, July 17, 2024. This trademark is owned by Imaginarium Future Limited. The PRIMOPUS trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals and of pharmaceutical formulations; custom manufacture of pharmaceuticals and biopharmaceuticals, namely, active pharmaceuticals

Pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, ocular, and bacteria-based related diseases and disorders, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations, and vaccines, and sanitary preparations for medical use; chemical, biochemical and biological products namely chemical, biochemical and biological reagents for medical use; agrochemical preparations in the nature of fungicides and herbicides

Chemical, biochemical and biological products for use in industry, science and scientific research, namely, chemical preparations for use in industry, biochemical preparations for scientific purposes, biological preparations for use in industry and science; diagnostic agents and reagents for use in industrial use, science and research; chemical and biological products and solutions namely Fmoc amino acids and phosphoramidites for use in science and in the manufacture of pharmaceuticals

Research and development of pharmaceuticals and biopharmaceuticals, namely, active pharmaceuticals for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, ocular, and bacteria-based related diseases and disorders, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations, and vaccines
primopus

General Information


Serial Number79373510
Word MarkPRIMOPUS
Filing DateFriday, December 9, 2022
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals and of pharmaceutical formulations; custom manufacture of pharmaceuticals and biopharmaceuticals, namely, active pharmaceuticals
Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, ocular, and bacteria-based related diseases and disorders, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations, and vaccines, and sanitary preparations for medical use; chemical, biochemical and biological products namely chemical, biochemical and biological reagents for medical use; agrochemical preparations in the nature of fungicides and herbicides
Goods and ServicesChemical, biochemical and biological products for use in industry, science and scientific research, namely, chemical preparations for use in industry, biochemical preparations for scientific purposes, biological preparations for use in industry and science; diagnostic agents and reagents for use in industrial use, science and research; chemical and biological products and solutions namely Fmoc amino acids and phosphoramidites for use in science and in the manufacture of pharmaceuticals
Goods and ServicesResearch and development of pharmaceuticals and biopharmaceuticals, namely, active pharmaceuticals for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, ocular, and bacteria-based related diseases and disorders, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations, and vaccines

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, July 7, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, July 7, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImaginarium Future Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, July 6, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 11, 2023APPLICATION FILING RECEIPT MAILED
Friday, September 15, 2023ASSIGNED TO EXAMINER
Friday, September 15, 2023NON-FINAL ACTION WRITTEN
Saturday, September 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, September 24, 2023LIMITATION OF GOODS RECEIVED FROM IB
Friday, September 29, 2023LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Friday, September 29, 2023REFUSAL PROCESSED BY MPU
Friday, September 29, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 31, 2023ATTORNEY REVIEW COMPLETED
Wednesday, October 25, 2023REFUSAL PROCESSED BY IB
Friday, May 31, 2024PETITION TO REVIVE-GRANTED
Friday, April 12, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, April 12, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, April 12, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, May 31, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, May 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 17, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 17, 2024FINAL REFUSAL E-MAILED
Wednesday, July 17, 2024FINAL REFUSAL WRITTEN
Monday, June 17, 2024ASSIGNED TO LIE